A passage opens by describing a marine biologist's decade-long study of bioluminescent organisms, then pivots to examine how pharmaceutical companies have commercialized compounds derived from those organisms, and closes by arguing that profit-sharing agreements between corporations and research institutions remain inadequate. Which of the following best captures the central idea of the passage? A) Marine biologists deserve greater recognition for their contributions to pharmaceutical development. B) The commercialization of scientific discoveries raises unresolved questions about equitable compensation for foundational researchers. C) Bioluminescent organisms represent the most promising frontier in modern pharmaceutical research. D) Profit-sharing agreements between corporations and universities have improved significantly in recent decades.

Remaining questions and full explanations are VIP-exclusive.